Publications by Dr Amir Enshaei - ePrints

Browsing publications by Dr Amir Enshaei.

Newcastle Authors	Title	Year
Dr Amir Enshaei Melvin Joy Ellie Butler Professor Anthony Moorman	A robust and validated integrated prognostic index for defining risk groups in adult acute lymphoblastic leukemia: an EWALL collaborative study	2024
Professor Anthony Moorman Dr Amir Enshaei Daniel Murdy Melvin Joy	Integration of genetics and MRD to define low risk patients with B-cell precursor acute lymphoblastic leukaemia with intermediate MRD levels at the end of induction	2024
Melvin Joy Dr Amir Enshaei Professor Anthony Moorman	Cranial radiotherapy has minimal benefit in children with central nervous system involvement in T-ALL	2023
Dr Paul Sinclair Dr Ruth Cranston Prahlad Raninga Joanna Cheng Rebecca Hanna et al.	Disruption to the FOXO-PRDM1 axis resulting from deletions of chromosome 6 in acute lymphoblastic leukaemia	2023
Claire Schwab Dr Ruth Cranston Dr Sarra Ryan Ellie Butler Emily Winterman et al.	Integrative genomic analysis of childhood acute lymphoblastic leukaemia lacking a genetic biomarker in the UKALL2003 clinical trial	2023
Dr Simon Bomken Dr Amir Enshaei Dr Ed Schwalbe Dr Aneta Mikulasova Dr Masood Zaka et al.	Molecular characterisation and clinical outcome of B-cell precursor acute lymphoblastic leukaemia with IG-MYC rearrangement	2023
Dr Amir Enshaei Jude Gibson Dr Sulaiman Lawal Professor Anthony Moorman	Real-world evaluation of UK high hyperdiploidy profile using a large cohort of patients provided by HARMONY data platform	2023
Dr Amir Enshaei Professor Anthony Moorman	The Prognostic Effect of IKZF1 Deletions in ETV6::RUNX1 and High Hyperdiploid Childhood Acute Lymphoblastic Leukemia	2023
Dr Amir Enshaei Dr Noura Al Moubayed	Generating Textual Explanations for Machine Learning Models Performance: A Table-to-Text Task	2022
Claire Schwab Daniel Murdy Ellie Butler Dr Amir Enshaei Emily Winterman et al.	Genetic characterisation of childhood B-other-acute lymphoblastic leukaemia in UK patients by fluorescence in situ hybridisation and Multiplex Ligation-dependent Probe Amplification	2022
Dr Alex Newman Dr Masood Zaka Dr Peixun Zhou Dr Alex Blain Dr Amy Erhorn et al.	Genomic abnormalities of TP53 define distinct risk groups of paediatric B-cell non-Hodgkin lymphoma	2022
Dr Carmela Ciardullo Dr Katarzyna Szoltysek Dr Peixun Zhou Dr Elaine Willmore Dr Amir Enshaei et al.	Low BACH2 expression predicts adverse outcome in chronic lymphocytic leukaemia	2022
Professor Anthony Moorman Emilio Barretta Ellie Butler Eleanor Ward Dr Amir Enshaei et al.	Prognostic impact of chromosomal abnormalities and copy number alterations in adult B-cell precursor acute lymphoblastic leukaemia: a UKALL14 study	2022
Professor Anthony Moorman Dr Grace Antony Ellie Butler Dr Amir Enshaei Professor Christine Harrison FRCPath FMedSci et al.	Time to Cure for Childhood and Young Adult Acute Lymphoblastic Leukemia Is Independent of Early Risk Factors: Long-Term Follow-Up of the UKALL2003 Trial	2022
Dr Amir Enshaei Professor Anthony Moorman	Defining low-risk high hyperdiploidy in patients with paediatric acute lymphoblastic leukaemia: a retrospective analysis of data from the UKALL97/99 and UKALL2003 clinical trials	2021
Dr Amir Enshaei	Finding the Ground-Truth from Multiple Labellers: Why Parameters of the Task Matter	2021
Dr Amir Enshaei	Fully-Automatic Pipeline for Document Signature Analysis to Detect Money Laundering Activities	2021
Dr Amir Enshaei	Minimal residual disease, long-term outcome, and IKZF1 deletions in children and adolescents with Down syndrome and acute lymphocytic leukaemia: a matched cohort study	2021
Dr Amir Enshaei Professor Anthony Moorman	Minimal Residual Disease, Long-Term Outcome, and IKZF1 Deletions in Down Syndrome Acute Lymphoblastic Leukemia in a Matched Cohort Study	2021
Yuzhe Shi Melanie Beckett Dr Helen Blair Dr Ricky Tirtakusuma Dr Sirintra Nakjang et al.	Phase II-like murine trial identifies synergy between dexamethasone and dasatinib in T-cell acute lymphoblastic leukemia	2021
Dr Tom Creasey Dr Amir Enshaei Claire Schwab Kathryn Watts Gavin Cuthbert et al.	Single nucleotide polymorphism (SNP) array-based signature of low hypodiploidy in acute lymphoblastic leukemia	2021
Dr Amir Enshaei Dr Sirintra Nakjang Lynne Minto Professor Julie Irving Beth Poole et al.	The genomic landscape of teenage and young adult T-cell acute lymphoblastic leukemia	2021
Dr Amir Enshaei Professor Christine Harrison FRCPath FMedSci Claire Schwab Professor Anthony Moorman	A validated novel continuous prognostic index to deliver stratified medicine in pediatric acute lymphoblastic leukemia	2020
Dr Matthew Bashton Robin Hollis Dr Sarra Ryan Claire Schwab Professor Christine Harrison FRCPath FMedSci et al.	Concordance of copy number abnormality detection using SNP arrays and Multiplex Ligation-dependent Probe Amplification (MLPA) in acute lymphoblastic leukaemia	2020
Dr Matthew Bashton Dr Amir Enshaei	Molecular Characterisation of Participants in the Phazar Trial Reveals Prognostic Impact of Mutations in Advanced-Phase-MPN	2020
Professor Anthony Moorman Dr Amir Enshaei Dr Tobias Menne	Clinical Efficacy of a Novel Validated Prognostic Index for Trial Design in Adult Acute Lymphoblastic Leukaemia	2019
Dr Amir Enshaei Professor Anthony Moorman	Combining Genotype Profiling with MRD for More Accurate Prognostication in Acute Lymphoblastic Leukemia	2019
Professor Anthony Moorman Dr Amir Enshaei	Minimal Residual Disease and IKZF1 As Predictors of Relapse, and Increased Treatment Related Mortality in Down Syndrome Acute Lymphoblastic Leukemia: A Unique and Large International Matched Case-Control Study	2019
Dr Tom Creasey Dr Amir Enshaei Kathryn Watts Gavin Cuthbert Claire Schwab et al.	Single Nucleotide Polymorphism Array-Based Signature of Genetic Ploidy Groups in Acute Lymphoblastic Leukemia	2019
Dr Lina Hamadeh Dr Amir Enshaei Claire Schwab Professor Christine Harrison FRCPath FMedSci Professor Anthony Moorman et al.	Validation of the United Kingdom copy-number alteration classifier in 3239 children with B-cell precursor ALL	2019
Dr Peixun Zhou Dr Amir Enshaei Alex Newman Dr Amy Erhorn Amy Barnard et al.	A genomic classification model enables risk stratification of paediatric endemic Burkitt lymphoma	2018
Dr Peixun Zhou Dr Amir Enshaei Alex Newman Dr Amy Erhorn Amy Barnard et al.	A Genomic Classification Model Enables Risk Stratification of Paediatric Endemic Burkitt Lymphona in Malawi	2018
Alex Newman Dr Masood Zaka Dr Peixun Zhou Dr Amy Erhorn Dr Rachel Crossland et al.	Biallelic inactivation of TP53 is associated with an increased risk of relapse in paediatric B-cell non-Hodgkin lymphoma (B-NHL)	2018
Dr Amir Enshaei Professor Christine Harrison FRCPath FMedSci Dr Sujith Samarasinghe Claire Schwab Professor Anthony Moorman et al.	Genotype-Specific Minimal Residual Disease Interpretation Improves Stratification in Pediatric Acute Lymphoblastic Leukemia	2017
Dr Ed Schwalbe Dr Debbie Hicks Dr Reza Rafiee Dr Matthew Bashton Dr Amir Enshaei et al.	Minimal methylation classifier (MIMIC): A novel method for derivation and rapid diagnostic detection of disease-associated DNA methylation signatures	2017
Dr Carmela Ciardullo Dr Elaine Willmore Dr Amir Enshaei Dr Peixun Zhou Dr Vikki Rand et al.	BACH2 and BCL6 Cooperatively Fuction as Tumour Suppressors in CLL	2016
Dr Lisa Russell Lisa Jones Dr Amir Enshaei Dr Stefano Tonin Sarra Ryan et al.	Characterisation of the genomic landscape of CRLF2-rearranged acute lymphoblastic leukemia	2016
Professor Anthony Moorman Dr Amir Enshaei Dr Sujith Samarasinghe	Integrating Genetic Risk Factors with Age, Presenting White Cell Count and MRD Response As Continuous Variables to Predict Relapse in Paediatric Acute Lymphoblastic Leukemia (ALL)	2016
Professor Julie Irving Dr Amir Enshaei Dr Amy Erhorn Lynne Minto Claire Schwab et al.	Integration of genetic and clinical risk factors improves prognostication in relapsed childhood B-cell precursor acute lymphoblastic leukaemia	2016
Dr Ed Schwalbe Dr Debbie Hicks Dr Reza Rafiee Dr Matthew Bashton Dr Amir Enshaei et al.	Routine Diagnostic Medulloblastoma Subgrouping Using Low-Cost, Low-Input DNA Methylomics: Application to Trials Cohorts Previously Refractory-to-Analysis	2016
Dr Ed Schwalbe Dr Debbie Hicks Dr Reza Rafiee Dr Matthew Bashton Dr Amir Enshaei et al.	Routine molecular subgrouping of medulloblastoma: Bridging the divide between research and the clinic using low-cost, mass spectrometry-based DNA methylomics	2016
Claire Schwab Dr Amir Enshaei Dr Lisa Russell Professor Anthony Moorman	The Frequency and Outcome of Ph-like ALL Associated Abnormalities in Childhood Acute Lymphoblastic Leukaemia Treated on MRC UKALL2003	2016
Dr Paul Sinclair Joanna Cheng Prahlad Raninga Rebecca Hanna Shaun Hollern et al.	A Targeted Functional Clone Tracking Assay for the Identification of Tumour Suppressor Genes in BCP- ALL Implicates the Transcription Factors FOXO3 and PRDM1	2015
Dr Al Gabriel Dr Amir Enshaei Jennifer Taylor Dr Amy Erhorn Claire Schwab et al.	Age specific incidence of partner gene and secondary abnormalities in MLL positive acute lymphoblastic leukaemia (ALL)	2015
Dr Amir Enshaei Professor Craig Robson Professor Richard Edmondson	Artificial Intelligence Systems as Prognostic and Predictive Tools in Ovarian Cancer	2015
Dr Lisa Russell Lisa Jones Dr Amir Enshaei Jamie Rutherford Dr Stefano Tonin et al.	Clincial and Genetic Landscapes Differ Between IGH-CRLF2 and P2RY8-CRLF2 Acute Lymphoblastic Leukaemia	2015
Dr Lisa Russell Lisa Jones Dr Amir Enshaei Dr Stefano Tonin Dr Sarra Ryan et al.	Clincial and Genetic Landscapes Differ Between IGH-CRLF2 and P2RY8-CRLF2 Acute Lymphoblastic Leukaemia	2015
Professor Anthony Moorman Professor Julie Irving Dr Amir Enshaei Dr Amy Erhorn Lynne Minto et al.	Composite Index for Risk Prediction in Relapsed Childhood Acute Lymphoblastic Leukaemia	2015
Dr Al Gabriel Fadhel Alsaid Naji Dr Ed Schwalbe Dr Sirintra Nakjang Dr Simon Cockell et al.	Epigenetic landscape correlates with genetic subtype but does not predict outcome in childhood acute lymphoblastic leukemia	2015
Dr Amir Enshaei	Feature Selection with Targeted Projection Pursuit	2015
Dr Dino Masic Dr Amir Enshaei Lisa Jones Professor Christine Harrison FRCPath FMedSci Dr Lisa Russell et al.	Genetic Characterisation of Immunoglobulin Heavy Chain Locus CCAAT Enhancer-Binding Protein Translocated Acute Lymphoblastic Leukaemia	2015
Dino Mašić Dr Amir Enshaei Lisa Jones Professor Christine Harrison FRCPath FMedSci Dr Lisa Russell et al.	Genetic Characterisation of Immunoglobulin Heavy Chain Locus CCAAT Enhancer-Binding Protein Translocated Acute Lymphoblastic Leukaemia	2015
Dr Amir Enshaei Professor Anthony Moorman Professor Christine Harrison FRCPath FMedSci Dr Sujith Samarasinghe	Integration of Minimal Residual Disease with Other Patient Risk Factors Identifies a Population with Very Poor Overall Survival in Pediatric ALL: Results from the UKALL 2003 Trial	2015
Dr Amir Enshaei Professor Anthony Moorman Professor Christine Harrison FRCPath FMedSci Dr Sujith Samarasinghe	Long Term Overall Survival of Greater Than 98% in Childhood ALL Patients with Good Risk Features and Low Risk MRD: Results from a Large Multi-Center Randomized Controlled Trial, UKALL 2003	2015
Dr Amir Enshaei Professor Anthony Moorman Professor Christine Harrison FRCPath FMedSci Dr Sujith Samarasinghe	Long Term Overall Survival of Greater Than 98% in Childhood ALL Patients with Good Risk Features and Low Risk MRD:A Results from a Large Multi-Center Randomized Controlled Trial, UKALL 2003	2015
Claire Schwab Dr Amir Enshaei Professor Anthony Moorman	Prognostic value of rare IKZF1 deletion in childhood b-cell precursor acute lymphoblastic leukemia: an international collaborative study	2015
Dr Amir Enshaei Claire Schwab Dr Lucy Chilton Professor Christine Harrison FRCPath FMedSci Professor Anthony Moorman et al.	Risk Factor Analysis in Paediatric Acute Lymphoblastic Leukaemia with High Hyperdiploidy	2015
Dr Amir Enshaei Claire Schwab Dr Lucy Chilton Professor Anthony Moorman	Risk Factor Analysis in Paediatric Acute Lymphoblastic Leukaemia with High Hyperdiploidy	2015
Dr Lisa Russell Dr Amir Enshaei Lisa Jones Dr Amy Erhorn Dr Dino Masic et al.	IGH@ Translocations Are Prevalent in Teenagers and Young Adults With Acute Lymphoblastic Leukemia and Are Associated With a Poor Outcome	2014
Claire Schwab Dr Amir Enshaei Professor Anthony Moorman	368 Prognostic Value of Rare IKZF1 deletions in Childhood B-Cell Precursor Acute Lymphoblastic Leukemia: An International Collaborative Study	2014
Professor Anthony Moorman Dr Amir Enshaei Claire Schwab Dr Lucy Chilton Alannah Elliott et al.	A novel integrated cytogenetic and genomic classification refines risk stratification in pediatric acute lymphoblastic leukemia	2014
Fadhel Alsaid Naji Dr Vikki Rand Professor Anthony Moorman Dr Ed Schwalbe Dr Amir Enshaei et al.	Investigation of methylation based biomarkers for prediction of relapse in good prognostic cytogenetic subgroups of childhood acute lymphoblastic leukaemia	2014
Claire Schwab Dr Amir Enshaei Professor Anthony Moorman	Prognostic Value of Rare IKZF1 deletions in Childhood B-Cell Precursor Acute Lymphoblastic Leukemia: An International Collaborative Study	2014
Dr Ed Schwalbe Dr Debbie Hicks Dr Reza Rafiee Dr Amir Enshaei Sandeep Potluri et al.	Routine molecular subgrouping of medulloblastoma: Bridging the divide between research and the clinic using low-cost DNA methylomics	2014
Professor Anthony Moorman Dr Amir Enshaei Claire Schwab Dr Lucy Chilton	Integration Of Cytogenetic and Copy Number Alteration (CNA) Data Into a Single Risk Profile For Paediatric Acute Lymphoblastic Leukaemia (ALL)	2013
Dr Amir Enshaei Claire Schwab Professor Christine Harrison FRCPath FMedSci Professor Anthony Moorman	Long-term follow-up of ETV6-RUNX1 ALL reveals that NCI risk, rather than secondary genetic abnormalities, is the key risk factor	2013
Professor Anthony Moorman Dr Lucy Chilton Dr Amir Enshaei Professor Christine Harrison FRCPath FMedSci	The clinical characteristics, therapy and outcome of 85 adults with acute lymphoblastic leukemia and t(4;11)(q21;q23)/MLL-AFF1 prospectively treated on UKALLXII/ECOG2993	2013
Professor Anthony Moorman Dr Lucy Chilton Dr Amir Enshaei Professor Christine Harrison FRCPath FMedSci	The clinical characteristics, therapy and outcome of 85 adults with acute lymphoblastic leukemia and t(4;11)(q21;q23)/MLL-AFF1 prospectively treated in the UKALLXII/ECOG2993 trial	2013
Claire Schwab Dr Lucy Chilton Dr Amir Enshaei Heather Morrison Lisa Jones et al.	Clinical Relevance of Genes Commonly Deleted in Childhood B-Cell Precursor ALL (BCP-ALL)	2012
Professor Anthony Moorman Dr Amir Enshaei Dr Lucy Chilton Claire Schwab Professor Christine Harrison FRCPath FMedSci et al.	Delineation of Risk Factors in Paediatric Acute Lymphoblastic Leukaemia with Favourable Cytogenetics	2012
Dr Lisa Russell Lisa Jones Dr Amy Erhorn Dr Amir Enshaei Dino Mašić et al.	Immunoglobulin Heavy Chain Locus (IGH@) Translocations in Childhood B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL): Incidence and Risk Stratification	2012